Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Bruce Ponder

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Physiology

Chemicals & Drugs

Genes & Molecular Sequences

Concepts & Ideas

Anatomy

Chromosomes, Human, Pair 10

Procedures

Case-Control Studies

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Mavaddat Nasim; Dunning Alison M; Ponder Bruce A J; Easton Douglas F; Pharoah Paul D
Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.
Pooley Karen A; Baynes Caroline; Driver Kristy E; Tyrer Jonathan; Azzato Elizabeth M; Pharoah Paul D P; Easton Douglas F; Ponder Bruce A J; Dunning Alison M
Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk.
Song Honglin; Koessler Thibaud; Ahmed Shahana; Ramus Susan J; Kjaer Susanne Krüger; Dicioccio Richard A; Wozniak Eva; Hogdall Estrid; Whittemore Alice S; McGuire Valerie; Ponder Bruce A J; Turnbull Clare; Hines Sarah; Rahman Nazneen; Eeles Rosalind A; Easton Douglas F; Gayther Simon A; Dunning Alison M; Pharoah Paul D P
Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Bruce Ponder (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Mavaddat Nasim; Dunning Alison M; Ponder Bruce A J; Easton Douglas F; Pharoah Paul D
Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(1):255-9.
2008: Pooley Karen A; Baynes Caroline; Driver Kristy E; Tyrer Jonathan; Azzato Elizabeth M; Pharoah Paul D P; Easton Douglas F; Ponder Bruce A J; Dunning Alison M
Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(12):3482-9.
2008: Song Honglin; Koessler Thibaud; Ahmed Shahana; Ramus Susan J; Kjaer Susanne Krüger; Dicioccio Richard A; Wozniak Eva; Hogdall Estrid; Whittemore Alice S; McGuire Valerie; Ponder Bruce A J; Turnbull Clare; Hines Sarah; Rahman Nazneen; Eeles Rosalind A; Easton Douglas F; Gayther Simon A; Dunning Alison M; Pharoah Paul D P
Association study of prostate cancer susceptibility variants with risks of invasive ovarian, breast, and colorectal cancer.
Cancer research 2008;68(21):8837-42.
2008: Mann Andrea; Hogdall Estrid; Ramus Susan J; DiCioccio Richard A; Hogdall Claus; Quaye Lydia; McGuire Valerie; Whittemore Alice S; Shah Mitul; Greenberg David; Easton Douglas F; Ponder Bruce A J; Kjaer Susanne Krüger; Gayther Simon A; Thompson Deborah J; Pharoah Paul D P; Song Honglin
Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients.
European journal of cancer (Oxford, England : 1990) 2008;44(15):2259-65.
2008: Quaye Lydia; Gayther Simon A; Ramus Susan J; Di Cioccio Richard A; McGuire Valerie; Hogdall Estrid; Hogdall Claus; Blaakr Jan; Easton Douglas F; Ponder Bruce A J; Jacobs Ian; Kjaer Susanne Kruger; Whittemore Alice S; Pearce Celeste Leigh; Pharoah Paul D P; Song Honglin
The effects of common genetic variants in oncogenes on ovarian cancer survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(18):5833-9.
2008: Barnett Gillian C; Shah Mitul; Redman Karen; Easton Douglas F; Ponder Bruce A J; Pharoah Paul D P
Risk factors for the incidence of breast cancer: do they affect survival from the disease?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(20):3310-6.
2008: Pharoah Paul D P; Antoniou Antonis C; Easton Douglas F; Ponder Bruce A J
Polygenes, risk prediction, and targeted prevention of breast cancer.
The New England journal of medicine 2008;358(26):2796-803.
2008: Meyer Kerstin B; Maia Ana-Teresa; O'Reilly Martin; Teschendorff Andrew E; Chin Suet-Feung; Caldas Carlos; Ponder Bruce A J
Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer.
PLoS biology 2008;6(5):e108.
2008: Driver Kristy E; Song Honglin; Lesueur Fabienne; Ahmed Shahana; Barbosa-Morais Nuno L; Tyrer Jonathan P; Ponder Bruce A J; Easton Douglas F; Pharoah Paul D P; Dunning Alison M;
Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population.
Carcinogenesis 2008;29(2):333-41.
2008: Mulvany Frances; Ponder Bruce A J
Breast Cancer Research--the first ten years.
Breast cancer research : BCR 2008;10(2):103.
2007: Ramus Susan J; Harrington Patricia A; Pye Carole; DiCioccio Richard A; Cox Mark J; Garlinghouse-Jones Kim; Oakley-Girvan Ingrid; Jacobs Ian J; Hardy Richard M; Whittemore Alice S; Ponder Bruce A J; Piver M Steven; Pharoah Paul D P; Gayther Simon A
Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.
Human mutation 2007;28(12):1207-15.
2007: Ruiz-Llorente Sergio; Montero-Conde Cristina; Milne Roger L; Moya Christian M; Cebrián Arancha; Letón Rocío; Cascón Alberto; Mercadillo Fátima; Landa Iñigo; Borrego Salud; Pérez de Nanclares Guiomar; Alvarez-Escolá Cristina; Díaz-Pérez José Angel; Carracedo Angel; Urioste Miguel; González-Neira Anna; Benítez Javier; Santisteban Pilar; Dopazo Joaquín; Ponder Bruce A; Robledo Mercedes;
Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinoma.
Cancer research 2007;67(19):9561-7.
2007: Udler Miriam; Maia Ana-Teresa; Cebrian Arancha; Brown Clement; Greenberg David; Shah Mitul; Caldas Carlos; Dunning Alison; Easton Douglas; Ponder Bruce; Pharoah Paul
Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(21):3015-23.
2007: Ramus Susan J; Harrington Patricia A; Pye Carole; Peock Susan; Cook Margaret R; Cox Mark J; Jacobs Ian J; DiCioccio Richard A; Whittemore Alice S; Piver M Steven; EMBRACE; Easton Douglas F; Ponder Bruce A J; Pharoah Paul D P; Gayther Simon A
Screening for the BRCA1-ins6kbEx13 mutation: potential for misdiagnosis. Mutation in brief #964. Online.
Human mutation 2007;28(5):525-6.
2007: Samuelson David J; Hesselson Stephanie E; Aperavich Beth A; Zan Yunhong; Haag Jill D; Trentham-Dietz Amy; Hampton John M; Mau Bob; Chen Kai-Shun; Baynes Caroline; Khaw Kay-Tee; Luben Robert; Perkins Barbara; Shah Mitul; Pharoah Paul D; Dunning Alison M; Easton Doug F; Ponder Bruce A; Gould Michael N
Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(15):6299-304.
2007: Pharoah Paul D P; Tyrer Jonathan; Dunning Alison M; Easton Douglas F; Ponder Bruce A J;
Association between common variation in 120 candidate genes and breast cancer risk.
PLoS genetics 2007;3(3):e42.
2007: Baynes Caroline; Healey Catherine S; Pooley Karen A; Scollen Serena; Luben Robert N; Thompson Deborah J; Pharoah Paul D P; Easton Douglas F; Ponder Bruce A J; Dunning Alison M;
Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.
Breast cancer research : BCR 2007;9(2):R27.
2007: Song Honglin; Ramus Susan J; Kjaer Susanne Krüger; Hogdall Estrid; Dicioccio Richard A; Whittemore Alice S; McGuire Valerie; Hogdall Claus; Jacobs Ian J; Easton Douglas F; Ponder Bruce A J; Dunning Alison M; Gayther Simon A; Pharoah Paul D P
Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer.
PloS one 2007;2(3):e268.
2006: Benusiglio P R; Pharoah P D; Smith P L; Lesueur F; Conroy D; Luben R N; Dew G; Jordan C; Dunning A; Easton D F; Ponder B A J
HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer.
British journal of cancer 2006;95(12):1689-95.
2006: Sternlicht Mark D; Dunning Alison M; Moore Dan H; Pharoah Paul D P; Ginzinger David G; Chin Koei; Gray Joe W; Waldman Frederic M; Ponder Bruce A J; Werb Zena
Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(11):2107-14.
2006: Song Honglin; Ramus Susan J; Quaye Lydia; DiCioccio Richard A; Tyrer Jonathan; Lomas Emma; Shadforth Danielle; Hogdall Estrid; Hogdall Claus; McGuire Valerie; Whittemore Alice S; Easton Douglas F; Ponder Bruce A J; Kjaer Susanne Kruger; Pharoah Paul D P; Gayther Simon A
Common variants in mismatch repair genes and risk of invasive ovarian cancer.
Carcinogenesis 2006;27(11):2235-42.
2006: Song Honglin; Ramus Susan J; Shadforth Danielle; Quaye Lydia; Kjaer Susanne Kruger; Dicioccio Richard A; Dunning Alison M; Hogdall Estrid; Hogdall Claus; Whittemore Alice S; McGuire Valerie; Lesueur Fabienne; Easton Douglas F; Jacobs Ian J; Ponder Bruce A J; Gayther Simon A; Pharoah Paul D P
Common variants in RB1 gene and risk of invasive ovarian cancer.
Cancer research 2006;66(20):10220-6.
2006: Cranston Aaron N; Carniti Cristiana; Oakhill Kim; Radzio-Andzelm Elzbieta; Stone Eric A; McCallion Andrew S; Hodgson Shirley; Clarke Sue; Mondellini Piera; Leyland Jean; Pierotti Marco A; Whittaker Joanne; Taylor Susan S; Bongarzone Italia; Ponder Bruce A J
RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B.
Cancer research 2006;66(20):10179-87.
2006: El-Tanani Mohamed K; Campbell Frederick Charles; Crowe Paul; Erwin Pauline; Harkin Denis Paul; Pharoah Paul; Ponder Bruce; Rudland Philip S
BRCA1 suppresses osteopontin-mediated breast cancer.
The Journal of biological chemistry 2006;281(36):26587-601.
2006: Warren Ruth; Skinner Jane; Sala Evis; Denton Erika; Dowsett Mitch; Folkerd Elizabeth; Healey Catherine S; Dunning Alison; Doody Deborah; Ponder Bruce; Luben Robert N; Day N E; Easton Douglas
Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(8):1502-8.
2006: Oestergaard M Z; Tyrer J; Cebrian A; Shah M; Dunning A M; Ponder B A J; Easton D F; Pharoah P D P
Interactions between genes involved in the antioxidant defence system and breast cancer risk.
British journal of cancer 2006;95(4):525-31.
2006: Cebrian Arancha; Pharoah Paul D; Ahmed Shahana; Ropero Santiago; Fraga Mario F; Smith Paula L; Conroy Don; Luben Robert; Perkins Barbara; Easton Douglas F; Dunning Alison M; Esteller Manel; Ponder Bruce A J
Genetic variants in epigenetic genes and breast cancer risk.
Carcinogenesis 2006;27(8):1661-9.
2006: Cranston Aaron; Carniti Cristiana; Martin Sam; Mondellini Piera; Hooks Yvette; Leyland Jean; Hodgson Shirley; Clarke Sue; Pierotti Marco; Ponder Bruce A J; Bongarzone Italia
A novel activating mutation in the RET tyrosine kinase domain mediates neoplastic transformation.
Molecular endocrinology (Baltimore, Md.) 2006;20(7):1633-43.
2006: Lesueur F; Song H; Ahmed S; Luccarini C; Jordan C; Luben R; Easton D F; Dunning A M; Pharoah P D; Ponder B A J
Single-nucleotide polymorphisms in the RB1 gene and association with breast cancer in the British population.
British journal of cancer 2006;94(12):1921-6.
2006: Pooley Karen A; Healey Catherine S; Smith Paula L; Pharoah Paul D P; Thompson Deborah; Tee Louise; West Judith; Jordan Clare; Easton Douglas F; Ponder Bruce A J; Dunning Alison M
Association of the progesterone receptor gene with breast cancer risk: a single-nucleotide polymorphism tagging approach.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(4):675-82.
2006: Carniti Cristiana; Belluco Sara; Riccardi Elena; Cranston Aaron N; Mondellini Piera; Ponder Bruce A J; Scanziani Eugenio; Pierotti Marco A; Bongarzone Italia
The Ret(C620R) mutation affects renal and enteric development in a mouse model of Hirschsprung's disease.
The American journal of pathology 2006;168(4):1262-75.
2006: Cebrian Arancha; Pharoah Paul D; Ahmed Shahana; Smith Paula L; Luccarini Craig; Luben Robert; Redman Karen; Munday Hannah; Easton Douglas F; Dunning Alison M; Ponder Bruce A J
Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer.
Cancer research 2006;66(2):1225-33.
2006: Lesueur Fabienne; Cebrian Arancha; Robledo Mercedes; Niccoli-Sire Patricia; Svensson Karl-Axel; Pinson Stephane; Leyland Jean; Whittaker Joanne; Pharoah Paul D; Ponder Bruce A J
Polymorphisms in RET and its coreceptors and ligands as genetic modifiers of multiple endocrine neoplasia type 2A.
Cancer research 2006;66(2):1177-80.
2006: Al-Zahrani Ali; Sandhu Manjinder S; Luben Robert N; Thompson Deborah; Baynes Caroline; Pooley Karen A; Luccarini Craig; Munday Hannah; Perkins Barbara; Smith Paula; Pharoah Paul D P; Wareham Nicholas J; Easton Douglas F; Ponder Bruce A J; Dunning Alison M
IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
Human molecular genetics 2006;15(1):1-10.
2005: Benusiglio Patrick R; Luccarini Craig; Ajai Oluseun; Ponder Bruce A J; Pharoah Paul D
Reply: a bias in genotyping of the ERBB2 (HER2) Ile655Val variant.
Carcinogenesis 2005;26(12):2213.
2005: Böckmann Miriam; Hilken Gero; Schmidt Anke; Cranston Aaron N; Tannapfel Andrea; Drosten Matthias; Frilling Andreja; Ponder Bruce A J; Pützer Brigitte M
Novel SRESPHP peptide mediates specific binding to primary medullary thyroid carcinoma after systemic injection.
Human gene therapy 2005;16(11):1267-75.
2005: Cebrian Arancha; Lesueur Fabienne; Martin Sam; Leyland Jean; Ahmed Shahana; Luccarini Craig; Smith Paula L; Luben Robert; Whittaker Joanne; Pharoah Paul D; Dunning Alison M; Ponder Bruce A J
Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 2005;90(11):6268-74.
2005: Auranen Annika; Song Honglin; Waterfall Christy; Dicioccio Richard A; Kuschel Bettina; Kjaer Susanne K; Hogdall Estrid; Hogdall Claus; Stratton John; Whittemore Alice S; Easton Douglas F; Ponder Bruce A J; Novik Karen L; Dunning Alison M; Gayther Simon; Pharoah Paul D P
Polymorphisms in DNA repair genes and epithelial ovarian cancer risk.
International journal of cancer. Journal international du cancer 2005;117(4):611-8.
2005: Lesueur Fabienne; Pharoah Paul D; Laing Stewart; Ahmed Shahana; Jordan Clare; Smith Paula L; Luben Robert; Wareham Nicholas J; Easton Douglas F; Dunning Alison M; Ponder Bruce A J
Allelic association of the human homologue of the mouse modifier Ptprj with breast cancer.
Human molecular genetics 2005;14(16):2349-56.
2005: Kuschel Bettina; Chenevix-Trench Georgia; Spurdle Amanda B; Chen Xiaoqing; Hopper John L; Giles Graham G; McCredie Margret; Chang-Claude Jenny; Gregory Catherine S; Day Nick E; Easton Douglas F; Ponder Bruce A J; Dunning Alison M; Pharoah Paul D P
Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(7):1828-31.
2005: Pharoah Paul D P; Dunning Alison M; Ponder Bruce A J; Easton Douglas F
The reliable identification of disease-gene associations.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(6):1362.
2005: Lesueur F; Cebrian A; Cranston A; Leyland J; Faid T M; Clements M R; Robledo M; Whittaker J; Ponder B A J
Germline homozygous mutations at codon 804 in the RET protooncogene in medullary thyroid carcinoma/multiple endocrine neoplasia type 2A patients.
The Journal of clinical endocrinology and metabolism 2005;90(6):3454-7.
2005: Cascon Alberto; Cebrian Arancha; Pollan Marina; Ruiz-Llorente Sergio; Montero-Conde Cristina; Leton Rocio; Gutierrez Ruth; Lesueur Fabienne; Milne Roger L; Gonzalez-Albarran Olga; Lucas-Morante Tomas; Benitez Javier; Ponder Bruce A J; Robledo Mercedes
Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 2005;90(4):2127-30.
2005: Hu S P; Day N E; Li D R; Luben R N; Cai K L; Ou-Yang T; Li B; Lu X Z; Ponder B A J
Further evidence for an HLA-related recessive mutation in nasopharyngeal carcinoma among the Chinese.
British journal of cancer 2005;92(5):967-70.
2005: Ponder B A J; Antoniou A; Dunning A; Easton D F; Pharoah P D P
Polygenic inherited predisposition to breast cancer.
Cold Spring Harbor symposia on quantitative biology 2005;70():35-41.
2005: Benusiglio Patrick R; Lesueur Fabienne; Luccarini Craig; McIntosh Joan; Luben Robert N; Smith Paula; Dunning Alison; Easton Douglas F; Ponder Bruce A J; Pharoah Paul D
Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.
BMC cancer 2005;5():81.
2005: Benusiglio Patrick R; Lesueur Fabienne; Luccarini Craig; Conroy Donald M; Shah Mitul; Easton Douglas F; Day Nick E; Dunning Alison M; Pharoah Paul D; Ponder Bruce Aj
Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study.
Breast cancer research : BCR 2005;7(2):R204-9.
2004: MacPherson Gordon; Healey Catherine S; Teare M Dawn; Balasubramanian Sabapathy P; Reed Malcolm W R; Pharoah Paul D P; Ponder Bruce A J; Meuth Mark; Bhattacharyya Nitai P; Cox Angela
Association of a common variant of the CASP8 gene with reduced risk of breast cancer.
Journal of the National Cancer Institute 2004;96(24):1866-9.
2004: Whittemore A S; Balise R R; Pharoah P D P; Dicioccio R A; Oakley-Girvan I; Ramus S J; Daly M; Usinowicz M B; Garlinghouse-Jones K; Ponder B A J; Buys S; Senie R; Andrulis I; John E; Hopper J L; Piver M S
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations.
British journal of cancer 2004;91(11):1911-5.
2004: Pharoah Paul D P; Dunning Alison M; Ponder Bruce A J; Easton Douglas F
Association studies for finding cancer-susceptibility genetic variants.
Nature reviews. Cancer 2004;4(11):850-60.
2004: Dicioccio Richard A; Song Honglin; Waterfall Christy; Kimura Makoto T; Nagase Hiroki; McGuire Valerie; Hogdall Estrid; Shah Mitul N; Luben Robert N; Easton Douglas F; Jacobs Ian J; Ponder Bruce A J; Whittemore Alice S; Gayther Simon A; Pharoah Paul D P; Kruger-Kjaer Susan
STK15 polymorphisms and association with risk of invasive ovarian cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(10):1589-94.
2004: Drosten Matthias; Hilken Gero; Böckmann Miriam; Rödicker Florian; Mise Nikica; Cranston Aaron N; Dahmen Uta; Ponder Bruce A J; Pützer Brigitte M
Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma.
Journal of the National Cancer Institute 2004;96(16):1231-9.
2004: Dunning Alison M; Dowsett Mitch; Healey Catherine S; Tee Louise; Luben Robert N; Folkerd Elizabeth; Novik Karen L; Kelemen Livia; Ogata Saeko; Pharoah Paul D P; Easton Douglas F; Day N E; Ponder Bruce A J
Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
Journal of the National Cancer Institute 2004;96(12):936-45.
2004: Daigo Yataro; Takayama Ichiro; Ponder Bruce A J; Caldas Carlos; Ward Sean M; Sanders Kenton M; Fujino Masayuki A
Novel human, mouse and xenopus genes encoding a member of the RAS superfamily of low-molecular-weight GTP-binding proteins and its downregulation in W/WV mouse jejunum.
Journal of gastroenterology and hepatology 2004;19(2):211-7.
2004: Werness Bruce A; Ramus Susan J; DiCioccio Richard A; Whittemore Alice S; Garlinghouse-Jones Kim; Oakley-Girvan Ingrid; Tsukada Yoshiaki; Harrington Patricia; Gayther Simon A; Ponder Bruce A J; Piver M Steven
Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2004;23(1):29-34.
2003: Hughes-Davies Luke; Huntsman David; Ruas Margarida; Fuks Francois; Bye Jacqueline; Chin Suet-Feung; Milner Jonathon; Brown Lindsay A; Hsu Forrest; Gilks Blake; Nielsen Torsten; Schulzer Michael; Chia Stephen; Ragaz Joseph; Cahn Anthony; Linger Lori; Ozdag Hilal; Cattaneo Elena; Jordanova E S; Schuuring Edward; Yu David S; Venkitaraman Ashok; Ponder Bruce; Doherty Aidan; Aparicio Samuel; Bentley David; Theillet Charles; Ponting Chris P; Caldas Carlos; Kouzarides Tony
EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.
Cell 2003;115(5):523-35.
2003: Cranston Aaron N; Ponder Bruce A J
Modulation of medullary thyroid carcinoma penetrance suggests the presence of modifier genes in a RET transgenic mouse model.
Cancer research 2003;63(16):4777-80.
2003: Kuschel B; Auranen A; Gregory C S; Day N E; Easton D F; Ponder B A J; Dunning A M; Pharoah Paul D P
Common polymorphisms in checkpoint kinase 2 are not associated with breast cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(8):809-12.
2003: Ewart-Toland Amanda; Briassouli Paraskevi; de Koning John P; Mao Jian-Hua; Yuan Jinwei; Chan Florence; MacCarthy-Morrogh Lucy; Ponder Bruce A J; Nagase Hiroki; Burn John; Ball Sarah; Almeida Maria; Linardopoulos Spiros; Balmain Allan
Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human.
Nature genetics 2003;34(4):403-12.
2003: Daigo Yataro; Takayama Ichiro; Ponder Bruce A J; Caldas Carlos; Ward Sean M; Sanders Kenton M; Fujino Masayuki A
Differential gene expression profile in the small intestines of mice lacking pacemaker interstitial cells of Cajal.
BMC gastroenterology 2003;3():17.
2003: Daigo Yataro; Takayama Ichiro; Ponder Bruce A J; Caldas Carlos; Ward Sean M; Sanders Kenton M; Fujino Masayuki A
Differential gene expression in the murine gastric fundus lacking interstitial cells of Cajal.
BMC gastroenterology 2003;3():14.
2003: Dunning Alison M; Ellis Peter D; McBride Simon; Kirschenlohr Heidi L; Healey Catherine S; Kemp Paul R; Luben Robert N; Chang-Claude Jenny; Mannermaa Arto; Kataja Vesa; Pharoah Paul D P; Easton Douglas F; Ponder Bruce A J; Metcalfe James C
A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer.
Cancer research 2003;63(10):2610-5.
2003: Ramus Susan J; Pharoah Paul D P; Harrington Patricia; Pye Carole; Werness Bruce; Bobrow Lynda; Ayhan Ayse; Wells Dagan; Fishman Ami; Gore Martin; DiCioccio Richard A; Piver M Steven; Whittemore Alice S; Ponder Bruce A J; Gayther Simon A
BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases.
Cancer research 2003;63(2):417-23.
2003: Edwards Stephen M; Kote-Jarai Zsofia; Meitz Julia; Hamoudi Rifat; Hope Questa; Osin Peter; Jackson Rachel; Southgate Christine; Singh Rashmi; Falconer Alison; Dearnaley David P; Ardern-Jones Audrey; Murkin Annette; Dowe Anna; Kelly Jo; Williams Sue; Oram Richard; Stevens Margaret; Teare Dawn M; Ponder Bruce A J; Gayther Simon A; Easton Doug F; Eeles Rosalind A;
Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.
American journal of human genetics 2003;72(1):1-12.
2003: Auranen Annika; Spurdle Amanda B; Chen Xiaoqing; Lipscombe Julian; Purdie David M; Hopper John L; Green Adele; Healey Catherine S; Redman Karen; Dunning Alison M; Pharoah Paul D; Easton Douglas F; Ponder Bruce A J; Chenevix-Trench Georgia; Novik Karen L
BRCA2 Arg372Hispolymorphism and epithelial ovarian cancer risk.
International journal of cancer. Journal international du cancer 2003;103(3):427-30.
2003: Weinhäusel Andreas; Behmel Annemarie; Ponder Bruce A J; Haas Oskar A; Niederle Bruno; Gessl Alois; Vierhapper Heinrich; Pfragner Roswitha
Long-term follow up of a "sporadic" unilateral pheochromocytoma revealing multiple endocrine neoplasia MEN2A-2 in an elderly woman.
Endocrine pathology 2003;14(4):375-82.
2003: Jordan V Craig; Ponder Bruce A J
Introducing a new section to Breast Cancer Research: endocrinology and hormone therapy.
Breast cancer research : BCR 2003;5(6):281-3.
2002: Ozdag H; Batley S J; Försti A; Iyer N G; Daigo Y; Boutell J; Arends M J; Ponder B A J; Kouzarides T; Caldas C
Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours.
British journal of cancer 2002;87(10):1162-5.
2002: Pharoah Paul D P; Ponder Bruce A J
The genetics of ovarian cancer.
Best practice & research. Clinical obstetrics & gynaecology 2002;16(4):449-68.
2002: Goode Ellen L; Dunning Alison M; Kuschel Bettina; Healey Catherine S; Day Nicholas E; Ponder Bruce A J; Easton Douglas F; Pharoah Paul P D
Effect of germ-line genetic variation on breast cancer survival in a population-based study.
Cancer research 2002;62(11):3052-7.
2002: Kuschel Bettina; Auranen Annika; McBride Simon; Novik Karen L; Antoniou Antonis; Lipscombe Julian M; Day Nicholas E; Easton Douglas F; Ponder Bruce A J; Pharoah Paul D P; Dunning Alison
Variants in DNA double-strand break repair genes and breast cancer susceptibility.
Human molecular genetics 2002;11(12):1399-407.
2002: Pharoah Paul D P; Antoniou Antonis; Bobrow Martin; Zimmern Ron L; Easton Douglas F; Ponder Bruce A J
Polygenic susceptibility to breast cancer and implications for prevention.
Nature genetics 2002;31(1):33-6.
2002: Tereschenko Irina V; Basham Victoria M; Ponder Bruce A J; Pharoah Paul D P
BRCA1 and BRCA2 mutations in Russian familial breast cancer.
Human mutation 2002;19(2):184.
2002: Basham Victoria M; Lipscombe Julian M; Ward Joanna M; Gayther Simon A; Ponder Bruce A J; Easton Douglas F; Pharoah Paul D P
BRCA1 and BRCA2 mutations in a population-based study of male breast cancer.
Breast cancer research : BCR 2002;4(1):R2.
2001: Basham V M; Pharoah P D; Healey C S; Luben R N; Day N E; Easton D F; Ponder B A; Dunning A M
Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk.
Carcinogenesis 2001;22(11):1797-800.
2001: Reynolds L; Jones K; Winton D J; Cranston A; Houghton C; Howard L; Ponder B A; Smith D P
C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET.
Oncogene 2001;20(30):3986-94.
2001: Antoniou A C; Pharoah P D; McMullan G; Day N E; Ponder B A; Easton D
Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
Genetic epidemiology 2001;21(1):1-18.
2001: Ponder B A
Cancer genetics.
Nature 2001;411(6835):336-41.
2001: Daigo Y; Chin S F; Gorringe K L; Bobrow L G; Ponder B A; Pharoah P D; Caldas C
Degenerate oligonucleotide primed-polymerase chain reaction-based array comparative genomic hybridization for extensive amplicon profiling of breast cancers : a new approach for the molecular analysis of paraffin-embedded cancer tissue.
The American journal of pathology 2001;158(5):1623-31.
2001: Kuschel B; Gayther S A; Easton D F; Ponder B A; Pharoah P D
Apparent human BRCA1 knockout caused by mispriming during polymerase chain reaction: implications for genetic testing.
Genes, chromosomes & cancer 2001;31(1):96-8.
2001: Ramus S J; Fishman A; Pharoah P D; Yarkoni S; Altaras M; Ponder B A
Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2001;27(3):278-81.
2000: Dunning A M; Durocher F; Healey C S; Teare M D; McBride S E; Carlomagno F; Xu C F; Dawson E; Rhodes S; Ueda S; Lai E; Luben R N; Van Rensburg E J; Mannermaa A; Kataja V; Rennart G; Dunham I; Purvis I; Easton D; Ponder B A
The extent of linkage disequilibrium in four populations with distinct demographic histories.
American journal of human genetics 2000;67(6):1544-54.
2000: Werness B A; Ramus S J; Whittemore A S; Garlinghouse-Jones K; Oakley-Girvan I; Dicioccio R A; Tsukada Y; Ponder B A; Piver M S
Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations.
Human pathology 2000;31(11):1420-4.
2000: Healey C S; Dunning A M; Teare M D; Chase D; Parker L; Burn J; Chang-Claude J; Mannermaa A; Kataja V; Huntsman D G; Pharoah P D; Luben R N; Easton D F; Ponder B A
A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability.
Nature genetics 2000;26(3):362-4.
2000: Werness B A; Ramus S J; Whittemore A S; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio R A; Tsukada Y; Ponder B A; Piver M S
Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2000;19(4):390-4.
2000: Huen D S; Elsdon M; Ponder B A
The Drosophila Ret gene is transcribed in multiple alternatively spliced forms.
Molecular & general genetics : MGG 2000;264(3):335-40.
2000: Gayther S A; de Foy K A; Harrington P; Pharoah P; Dunsmuir W D; Edwards S M; Gillett C; Ardern-Jones A; Dearnaley D P; Easton D F; Ford D; Shearer R J; Kirby R S; Dowe A L; Kelly J; Stratton M R; Ponder B A; Barnes D; Eeles R A
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.
Cancer research 2000;60(16):4513-8.
2000: Russell P A; Pharoah P D; De Foy K; Ramus S J; Symmonds I; Wilson A; Scott I; Ponder B A; Gayther S A
Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers.
International journal of cancer. Journal international du cancer 2000;87(3):317-21.
2000: Werness B A; Parvatiyar P; Ramus S J; Whittemore A S; Garlinghouse-Jones K; Oakley-Girvan I; DiCioccio R A; Wiest J; Tsukada Y; Ponder B A; Piver M S
Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
Journal of the National Cancer Institute 2000;92(13):1088-91.
2000: Sutcliffe S; Pharoah P D; Easton D F; Ponder B A
Ovarian and breast cancer risks to women in families with two or more cases of ovarian cancer.
International journal of cancer. Journal international du cancer 2000;87(1):110-7.
2000: Knowles C H; Gayther S A; Scott M; Ramus S; Anand P; Williams N S; Ponder B A
Idiopathic slow-transit constipation is not associated with mutations of the RET proto-oncogene or GDNF.
Diseases of the colon and rectum 2000;43(6):851-7.
2000: Pharoah P D; Lipscombe J M; Redman K L; Day N E; Easton D F; Ponder B A
Familial predisposition to breast cancer in a British population: implications for prevention.
European journal of cancer (Oxford, England : 1990) 2000;36(6):773-9.
2000: Lakhani S R; Gusterson B A; Jacquemier J; Sloane J P; Anderson T J; van de Vijver M J; Venter D; Freeman A; Antoniou A; McGuffog L; Smyth E; Steel C M; Haites N; Scott R J; Goldgar D; Neuhausen S; Daly P A; Ormiston W; McManus R; Scherneck S; Ponder B A; Futreal P A; Peto J; Stoppa-Lyonnet D; Bignon Y J; Stratton M R
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):782-9.
2000: Carlomagno F; Burnet N G; Turesson I; Nyman J; Peacock J H; Dunning A M; Ponder B A; Jackson S P
Comparison of DNA repair protein expression and activities between human fibroblast cell lines with different radiosensitivities.
International journal of cancer. Journal international du cancer 2000;85(6):845-9.
2000: Gayther S A; Batley S J; Linger L; Bannister A; Thorpe K; Chin S F; Daigo Y; Russell P; Wilson A; Sowter H M; Delhanty J D; Ponder B A; Kouzarides T; Caldas C
Mutations truncating the EP300 acetylase in human cancers.
Nature genetics 2000;24(3):300-3.
2000: Healey C S; Dunning A M; Durocher F; Teare D; Pharoah P D; Luben R N; Easton D F; Ponder B A
Polymorphisms in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk.
Carcinogenesis 2000;21(2):189-93.
2000: Antoniou A C; Gayther S A; Stratton J F; Ponder B A; Easton D F
Risk models for familial ovarian and breast cancer.
Genetic epidemiology 2000;18(2):173-90.
1999: Caldas C; Carneiro F; Lynch H T; Yokota J; Wiesner G L; Powell S M; Lewis F R; Huntsman D G; Pharoah P D; Jankowski J A; MacLeod P; Vogelsang H; Keller G; Park K G; Richards F M; Maher E R; Gayther S A; Oliveira C; Grehan N; Wight D; Seruca R; Roviello F; Ponder B A; Jackson C E
Familial gastric cancer: overview and guidelines for management.
Journal of medical genetics 1999;36(12):873-80.
1999: Stratton J F; Thompson D; Bobrow L; Dalal N; Gore M; Bishop D T; Scott I; Evans G; Daly P; Easton D F; Ponder B A
The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study.
American journal of human genetics 1999;65(6):1725-32.
1999: Dunning A M; McBride S; Gregory J; Durocher F; Foster N A; Healey C S; Smith N; Pharoah P D; Luben R N; Easton D F; Ponder B A
No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer.
Carcinogenesis 1999;20(11):2131-5.
1999: Dunning A M; Healey C S; Pharoah P D; Teare M D; Ponder B A; Easton D F
A systematic review of genetic polymorphisms and breast cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1999;8(10):843-54.
1999: Gayther S A; Russell P; Harrington P; Antoniou A C; Easton D F; Ponder B A
The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.
American journal of human genetics 1999;65(4):1021-9.
1999: Carlomagno F; Chang-Claude J; Dunning A M; Ponder B A
Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer.
Genes, chromosomes & cancer 1999;25(4):393-5.
1999: Ponder B A
Costs, benefits and limitations of genetic testing for cancer risk.
British journal of cancer 1999;80 Suppl 1():46-50.
1999: Lee H; Trainer A H; Friedman L S; Thistlethwaite F C; Evans M J; Ponder B A; Venkitaraman A R
Mitotic checkpoint inactivation fosters transformation in cells lacking the breast cancer susceptibility gene, Brca2.
Molecular cell 1999;4(1):1-10.
1999: Ramus S J; Bobrow L G; Pharoah P D; Finnigan D S; Fishman A; Altaras M; Harrington P A; Gayther S A; Ponder B A; Friedman L S
Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours.
Genes, chromosomes & cancer 1999;25(2):91-6.
1999: Ponder B A
The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome.
Cancer research 1999;59(7 Suppl):1736s-1741s; discussion 1742s.
1999: Csokay B; Udvarhelyi N; Sulyok Z; Besznyak I; Ramus S; Ponder B; Olah E
High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history.
Cancer research 1999;59(5):995-8.
1999: Pharoah P D; Easton D F; Stockton D L; Gayther S; Ponder B A
Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group.
Cancer research 1999;59(4):868-71.
1998: Eng C; Thomas G A; Neuberg D S; Mulligan L M; Healey C S; Houghton C; Frilling A; Raue F; Williams E D; Ponder B A
Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 1998;83(12):4310-3.
1998: Gayther S A; Pharoah P D; Ponder B A
The genetics of inherited breast cancer.
Journal of mammary gland biology and neoplasia 1998;3(4):365-76.
1998: Gayther S A; Gorringe K L; Ramus S J; Huntsman D; Roviello F; Grehan N; Machado J C; Pinto E; Seruca R; Halling K; MacLeod P; Powell S M; Jackson C E; Ponder B A; Caldas C
Identification of germ-line E-cadherin mutations in gastric cancer families of European origin.
Cancer research 1998;58(18):4086-9.
1998: Gayther S A; Ponder B A
Clues to the function of the tumour susceptibility gene BRCA2.
Disease markers 1998;14(1):1-8.
1998: Dunning A M; Healey C S; Pharoah P D; Foster N A; Lipscombe J M; Redman K L; Easton D F; Day N E; Ponder B A
No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer.
British journal of cancer 1998;77(11):2045-7.
1998: Neuhausen S L; Godwin A K; Gershoni-Baruch R; Schubert E; Garber J; Stoppa-Lyonnet D; Olah E; Csokay B; Serova O; Lalloo F; Osorio A; Stratton M; Offit K; Boyd J; Caligo M A; Scott R J; Schofield A; Teugels E; Schwab M; Cannon-Albright L; Bishop T; Easton D; Benitez J; King M C; Ponder B A; Weber B; Devilee P; Borg A; Narod S A; Goldgar D
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.
American journal of human genetics 1998;62(6):1381-8.
1998: Stratton J F; Pharoah P; Smith S K; Easton D; Ponder B A
A systematic review and meta-analysis of family history and risk of ovarian cancer.
British journal of obstetrics and gynaecology 1998;105(5):493-9.
1998: de Foy K A; Gayther S A; Colledge W H; Crockett S; Scott I V; Evans M J; Ponder B A
Mutation analysis of the c-mos proto-oncogene in human ovarian teratomas.
British journal of cancer 1998;77(10):1642-4.
1998: Bongarzone I; Vigano E; Alberti L; Borrello M G; Pasini B; Greco A; Mondellini P; Smith D P; Ponder B A; Romeo G; Pierotti M A
Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation.
Oncogene 1998;16(18):2295-301.
1998: Friedman L S; Thistlethwaite F C; Patel K J; Yu V P; Lee H; Venkitaraman A R; Abel K J; Carlton M B; Hunter S M; Colledge W H; Evans M J; Ponder B A
Thymic lymphomas in mice with a truncating mutation in Brca2.
Cancer research 1998;58(7):1338-43.
1998: Pfragner R; Behmel A; Smith D P; Ponder B A; Wirnsberger G; Rinner I; Porta S; Henn T; Niederle B
First continuous human pheochromocytoma cell line: KNA. Biological, cytogenetic and molecular characterization of KNA cells.
Journal of neurocytology 1998;27(3):175-86.
1998: Phelan C M; Borg A; Cuny M; Crichton D N; Baldersson T; Andersen T I; Caligo M A; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon Y J; Scherneck S; Barkardottir R; Borresen-Dale A L; Eyfjörd J; Theillet C; Thompson A M; Larsson C
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Cancer research 1998;58(5):1004-12.
1998: Ford D; Easton D F; Stratton M; Narod S; Goldgar D; Devilee P; Bishop D T; Weber B; Lenoir G; Chang-Claude J; Sobol H; Teare M D; Struewing J; Arason A; Scherneck S; Peto J; Rebbeck T R; Tonin P; Neuhausen S; Barkardottir R; Eyfjord J; Lynch H; Ponder B A; Gayther S A; Zelada-Hedman M
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
American journal of human genetics 1998;62(3):676-89.
1998: Patel K J; Yu V P; Lee H; Corcoran A; Thistlethwaite F C; Evans M J; Colledge W H; Friedman L S; Ponder B A; Venkitaraman A R
Involvement of Brca2 in DNA repair.
Molecular cell 1998;1(3):347-57.
1998: Davies B R; Worsley S D; Ponder B A
Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.
Histopathology 1998;32(1):69-80.
1998: Davies B R; Auersperg N; Worsley S D; Ponder B A
Transfection of rat ovarian surface epithelium with erb-B2/neu induces transformed phenotypes in vitro and the tumorigenic phenotype in vivo.
The American journal of pathology 1998;152(1):297-306.
1998: Ponder B A
Inherited predisposition to breast cancer.
Biochemical Society symposium 1998;63():223-30.
1997: Gayther S A; Barski P; Batley S J; Li L; de Foy K A; Cohen S N; Ponder B A; Caldas C
Aberrant splicing of the TSG101 and FHIT genes occurs frequently in multiple malignancies and in normal tissues and mimics alterations previously described in tumours.
Oncogene 1997;15(17):2119-26.
1997: Smith D P; Houghton C; Ponder B A
Germline mutation of RET codon 883 in two cases of de novo MEN 2B.
Oncogene 1997;15(10):1213-7.
1997: Pharoah P D; Day N E; Duffy S; Easton D F; Ponder B A
Family history and the risk of breast cancer: a systematic review and meta-analysis.
International journal of cancer. Journal international du cancer 1997;71(5):800-9.
1997: Caldas C; Ponder B A
Cancer genes and molecular oncology in the clinic.
Lancet 1997;349 Suppl 2():SII16-8.
1997: Ramus S J; Kote-Jarai Z; Friedman L S; van der Looij M; Gayther S A; Csokay B; Ponder B A; Olah E
Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer.
American journal of human genetics 1997;60(5):1242-6.
1997: Gayther S A; Harrington P; Russell P; Kharkevich G; Garkavtseva R F; Ponder B A
Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia.
American journal of human genetics 1997;60(5):1239-42.
1997: Gayther S A; Ponder B A
Mutations of the BRCA1 and BRCA2 genes and the possibilities for predictive testing.
Molecular medicine today 1997;3(4):168-74.
1997: Milner J; Ponder B; Hughes-Davies L; Seltmann M; Kouzarides T
Transcriptional activation functions in BRCA2.
Nature 1997;386(6627):772-3.
1997: Stratton J F; Gayther S A; Russell P; Dearden J; Gore M; Blake P; Easton D; Ponder B A
Contribution of BRCA1 mutations to ovarian cancer.
The New England journal of medicine 1997;336(16):1125-30.
1997: Dunning A M; Chiano M; Smith N R; Dearden J; Gore M; Oakes S; Wilson C; Stratton M; Peto J; Easton D; Clayton D; Ponder B A
Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population.
Human molecular genetics 1997;6(2):285-9.
1997: Lorenzo M J; Gish G D; Houghton C; Stonehouse T J; Pawson T; Ponder B A; Smith D P
RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2.
Oncogene 1997;14(7):763-71.
1997: Worsley S D; Ponder B A; Davies B R
Overexpression of cyclin D1 in epithelial ovarian cancers.
Gynecologic oncology 1997;64(2):189-95.
1997: Friedman L S; Gayther S A; Kurosaki T; Gordon D; Noble B; Casey G; Ponder B A; Anton-Culver H
Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population.
American journal of human genetics 1997;60(2):313-9.
1997: Gayther S A; Mangion J; Russell P; Seal S; Barfoot R; Ponder B A; Stratton M R; Easton D
Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene.
Nature genetics 1997;15(1):103-5.
1997: Ramus S J; Friedman L S; Gayther S A; Ponder B A; Bobrow L; van der Looji M; Papp J; Olah E
A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2.
Nature genetics 1997;15(1):14-5.
1996: Papp J; Csokay B; Bosze P; Zalay Z; Toth J; Ponder B; Olah E
Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas.
British journal of cancer 1996;74(10):1592-7.
1996: Mazoyer S; Dunning A M; Serova O; Dearden J; Puget N; Healey C S; Gayther S A; Mangion J; Stratton M R; Lynch H T; Goldgar D E; Ponder B A; Lenoir G M
A polymorphic stop codon in BRCA2.
Nature genetics 1996;14(3):253-4.
1996: Froggatt N J; Brassett C; Koch D J; Evans D G; Hodgson S V; Ponder B A; Maher E R
Mutation screening of MSH2 and MLH1 mRNA in hereditary non-polyposis colon cancer syndrome.
Journal of medical genetics 1996;33(9):726-30.
1996: Foster K A; Harrington P; Kerr J; Russell P; DiCioccio R A; Scott I V; Jacobs I; Chenevix-Trench G; Ponder B A; Gayther S A
Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer.
Cancer research 1996;56(16):3622-5.
1996: Eng C; Foster K A; Healey C S; Houghton C; Gayther S A; Mulligan L M; Ponder B A
Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
British journal of cancer 1996;74(3):339-41.
1996: Eng C; Mulligan L M; Healey C S; Houghton C; Frilling A; Raue F; Thomas G A; Ponder B A
Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma.
Cancer research 1996;56(9):2167-70.
1996: Gayther S A; Harrington P; Russell P; Kharkevich G; Garkavtseva R F; Ponder B A
Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group.
American journal of human genetics 1996;58(3):451-6.
1996: Marsh D J; Andrew S D; Eng C; Learoyd D L; Capes A G; Pojer R; Richardson A L; Houghton C; Mulligan L M; Ponder B A; Robinson B G
Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma.
Cancer research 1996;56(6):1241-3.
1996: Phelan C M; Rebbeck T R; Weber B L; Devilee P; Ruttledge M H; Lynch H T; Lenoir G M; Stratton M R; Easton D F; Ponder B A; Cannon-Albright L; Larsson C; Goldgar D E; Narod S A
Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus.
Nature genetics 1996;12(3):309-11.
1996: Mak Y F; Ponder B A
RET oncogene.
Current opinion in genetics & development 1996;6(1):82-6.
1996: Neuhausen S L; Mazoyer S; Friedman L; Stratton M; Offit K; Caligo A; Tomlinson G; Cannon-Albright L; Bishop T; Kelsell D; Solomon E; Weber B; Couch F; Struewing J; Tonin P; Durocher F; Narod S; Skolnick M H; Lenoir G; Serova O; Ponder B; Stoppa-Lyonnet D; Easton D; King M C; Goldgar D E
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study.
American journal of human genetics 1996;58(2):271-80.
1996: Ponder B A; Smith D
The MEN II syndromes and the role of the ret proto-oncogene.
Advances in cancer research 1996;70():179-222.
1995: Gayther S A; Warren W; Mazoyer S; Russell P A; Harrington P A; Chiano M; Seal S; Hamoudi R; van Rensburg E J; Dunning A M; Love R; Evans G; Easton D; Clayton D; Stratton M R; Ponder B A
Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.
Nature genetics 1995;11(4):428-33.
1995: Cornelis R S; Neuhausen S L; Johansson O; Arason A; Kelsell D; Ponder B A; Tonin P; Hamann U; Lindblom A; Lalle P
High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium.
Genes, chromosomes & cancer 1995;13(3):203-10.
1995: Eng C; Mulligan L M; Smith D P; Healey C S; Frilling A; Raue F; Neumann H P; Ponder M A; Ponder B A
Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.
Clinical endocrinology 1995;43(1):123-7.
1995: Mazoyer S; Gayther S A; Nagai M A; Smith S A; Dunning A; van Rensburg E J; Albertsen H; White R; Ponder B A
A gene (DLG2) located at 17q12-q21 encodes a new homologue of the Drosophila tumor suppressor dIg-A.
Genomics 1995;28(1):25-31.
1995: Froggatt N J; Koch J; Davies R; Evans D G; Clamp A; Quarrell O W; Weissenbach J; Hodgson S V; Ponder B A; Barton D E
Genetic linkage analysis in hereditary non-polyposis colon cancer syndrome.
Journal of medical genetics 1995;32(5):352-7.
1995: Lorenzo M J; Eng C; Mulligan L M; Stonehouse T J; Healey C S; Ponder B A; Smith D P
Multiple mRNA isoforms of the human RET proto-oncogene generated by alternate splicing.
Oncogene 1995;10(7):1377-83.
1995: Froggatt N J; Joyce J A; Davies R; Gareth D; Evans R; Ponder B A; Barton D E; Maher E R
A frequent hMSH2 mutation in hereditary non-polyposis colon cancer syndrome.
Lancet 1995;345(8951):727.
1995: Eng C; Smith D P; Mulligan L M; Healey C S; Zvelebil M J; Stonehouse T J; Ponder M A; Jackson C E; Waterfield M D; Ponder B A
A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC.
Oncogene 1995;10(3):509-13.
1995: Ponder B A
Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2.
Cancer surveys 1995;25():195-205.
1994: Feldman G L; Kambouris M; Talpos G B; Mulligan L M; Ponder B A; Jackson C E
Clinical value of direct DNA analysis of the RET proto-oncogene in families with multiple endocrine neoplasia type 2A.
Surgery 1994;116(6):1042-7.
1994: Gardner E; Mulligan L M; Eng C; Healey C S; Kwok J B; Ponder M A; Ponder B A
Haplotype analysis of MEN 2 mutations.
Human molecular genetics 1994;3(10):1771-4.
1994: Eng C; Murday V; Seal S; Mohammed S; Hodgson S V; Chaudary M A; Fentiman I S; Ponder B A; Eeles R A
Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy?
Journal of medical genetics 1994;31(6):458-61.
1994: Mulligan L M; Eng C; Healey C S; Ponder M A; Feldman G L; Li P; Jackson C E; Ponder B A
A de novo mutation of the RET proto-oncogene in a patient with MEN 2A.
Human molecular genetics 1994;3(6):1007-8.
1994: Ponder B A
The gene causing multiple endocrine neoplasia type 2 (MEN 2).
Annals of medicine 1994;26(3):199-203.
1994: McMahon R; Mulligan L M; Healey C S; Payne S J; Ponder M; Ferguson-Smith M A; Barton D E; Ponder B A
Direct, non-radioactive detection of mutations in multiple endocrine neoplasia type 2A families.
Human molecular genetics 1994;3(4):643-6.
1994: Eng C; Stratton M; Ponder B; Murday V; Easton D; Sacks N; Watson M; Eeles R
Familial cancer syndromes.
Lancet 1994;343(8899):709-13.
1994: Wooster R; Cleton-Jansen A M; Collins N; Mangion J; Cornelis R S; Cooper C S; Gusterson B A; Ponder B A; von Deimling A; Wiestler O D
Instability of short tandem repeats (microsatellites) in human cancers.
Nature genetics 1994;6(2):152-6.
1994: Smith D P; Eng C; Ponder B A
Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes and Hirschsprung disease.
Journal of cell science. Supplement 1994;18():43-9.
1993: Jackson M S; Slijepcevic P; Ponder B A
The organisation of repetitive sequences in the pericentromeric region of human chromosome 10.
Nucleic acids research 1993;21(25):5865-74.
1993: Smith S A; Ponder B A
Predisposing genes in breast and ovarian cancer: an overview.
Tumori 1993;79(5):291-6.
1993: Kwok J B; Gardner E; Warner J P; Ponder B A; Mulligan L M
Structural analysis of the human ret proto-oncogene using exon trapping.
Oncogene 1993;8(9):2575-82.
1993: Wooster R; Ford D; Mangion J; Ponder B A; Peto J; Easton D F; Stratton M R
Absence of linkage to the ataxia telangiectasia locus in familial breast cancer.
Human genetics 1993;92(1):91-4.
1993: Easton D F; Ponder M A; Huson S M; Ponder B A
An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes.
American journal of human genetics 1993;53(2):305-13.
1993: Eng C; Ponder B A
The role of gene mutations in the genesis of familial cancers.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1993;7(10):910-9.
1993: Love D R; Gardner E; Ponder B A
A polymorphic dinucleotide repeat at the ZNF22 locus.
Human molecular genetics 1993;2(4):491.
1993: Love D R; Gardner E; Ponder B A
A polymorphic dinucleotide repeat at the D10S141 locus.
Human molecular genetics 1993;2(4):491.
1993: Smith S A; Easton D F; Ford D; Peto J; Anderson K; Averill D; Stratton M; Ponder M; Pye C; Ponder B A
Genetic heterogeneity and localization of a familial breast-ovarian cancer gene on chromosome 17q12-q21.
American journal of human genetics 1993;52(4):767-76.
1993: Tunnacliffe A; Liu L; Moore J K; Leversha M A; Jackson M S; Papi L; Ferguson-Smith M A; Thiesen H J; Ponder B A
Duplicated KOX zinc finger gene clusters flank the centromere of human chromosome 10: evidence for a pericentric inversion during primate evolution.
Nucleic acids research 1993;21(6):1409-17.
1993: Mole S E; Mulligan L M; Healey C S; Ponder B A; Tunnacliffe A
Localisation of the gene for multiple endocrine neoplasia type 2A to a 480 kb region in chromosome band 10q11.2.
Human molecular genetics 1993;2(3):247-52.
1993: Jacobs I J; Smith S A; Wiseman R W; Futreal P A; Harrington T; Osborne R J; Leech V; Molyneux A; Berchuck A; Ponder B A
A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus.
Cancer research 1993;53(6):1218-21.
1993: Mulligan L M; Gardner E; Smith B A; Mathew C G; Ponder B A
Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2.
Genes, chromosomes & cancer 1993;6(3):166-77.
1993: Mole S E; Jackson M S; Tokino T; Nakamura Y; Ponder B A
Assignment of fifty-four cosmid clones to five regions of chromosome 10.
Genomics 1993;15(2):457-8.
1993: Ponder B A
Genetic screening for multiple endocrine neoplasia type 2.
Experimental and clinical endocrinology 1993;101(1):53-6.
1993: Telenius H; de Vos D; Blennow E; Willat L R; Ponder B A; Carter N P
Chromatid contamination can impair the purity of flow-sorted metaphase chromosomes.
Cytometry 1993;14(1):97-101.
1992: Blennow E; Telenius H; Larsson C; de Vos D; Bajalica S; Ponder B A; Nordenskjöld M
Complete characterization of a large marker chromosome by reverse and forward chromosome painting.
Human genetics 1992;90(4):371-4.
1992: Mulligan L M; Gardner E; Ponder B A
An SphI polymorphism at the ZNF22 locus.
Human molecular genetics 1992;1(7):551.
1992: Chambers J A; Gardner E; Hauptmann R; Ponder B A; Mulligan L M
TaqI polymorphisms at the annexin VIII locus (ANX8).
Human molecular genetics 1992;1(7):550.
1992: Mulligan L M; Gardner E; Ponder B A
An SphI polymorphism at the vinculin locus (VCL).
Human molecular genetics 1992;1(7):550.
1992: Wooster R; Mangion J; Eeles R; Smith S; Dowsett M; Averill D; Barrett-Lee P; Easton D F; Ponder B A; Stratton M R
A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome.
Nature genetics 1992;2(2):132-4.
1992: Smith S A; Easton D F; Evans D G; Ponder B A
Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome.
Nature genetics 1992;2(2):128-31.
1992: Jackson M S; Mole S E; Ponder B A
Characterisation of a boundary between satellite III and alphoid sequences on human chromosome 10.
Nucleic acids research 1992;20(18):4781-7.
1992: Papi L; Tunnacliffe A; Ponder B A
Dinucleotide repeat polymorphism at the RBP3 locus in chromosome band 10q11.2.
Human molecular genetics 1992;1(6):450.
1992: Mulligan L M; Gardner E; Telenius H; Ponder B A
Complementary physical and genetic techniques map the vinculin (VCL) gene on chromosome 10q.
Genomics 1992;13(4):1347-9.
1992: Rousseau-Merck M F; Tunnacliffe A; Berger R; Ponder B A; Thiesen H J
A cluster of expressed zinc finger protein genes in the pericentromeric region of human chromosome 10.
Genomics 1992;13(3):845-8.
1992: Telenius H; Carter N P; Bebb C E; Nordenskjöld M; Ponder B A; Tunnacliffe A
Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer.
Genomics 1992;13(3):718-25.
1992: Ponder B A
Neurofibromatosis: from gene to phenotype.
Seminars in cancer biology 1992;3(3):115-20.
1992: Xu W; Mulligan L M; Ponder M A; Liu L; Smith B A; Mathew C G; Ponder B A
Loss of NF1 alleles in phaeochromocytomas from patients with type I neurofibromatosis.
Genes, chromosomes & cancer 1992;4(4):337-42.
1992: Warren W; Eeles R A; Ponder B A; Easton D F; Averill D; Ponder M A; Anderson K; Evans A M; DeMars R; Love R
No evidence for germline mutations in exons 5-9 of the p53 gene in 25 breast cancer families.
Oncogene 1992;7(5):1043-6.
1992: Ponder B A
Molecular genetics of cancer.
BMJ (Clinical research ed.) 1992;304(6836):1234-6.
1992: Telenius H; Pelmear A H; Tunnacliffe A; Carter N P; Behmel A; Ferguson-Smith M A; Nordenskjöld M; Pfragner R; Ponder B A
Cytogenetic analysis by chromosome painting using DOP-PCR amplified flow-sorted chromosomes.
Genes, chromosomes & cancer 1992;4(3):257-63.
1992: Winton D J; Howard L; Ponder B A
Possible non-functional crypts in small intestine defined using mouse aggregation chimaeras.
Epithelial cell biology 1992;1(2):59-64.
1992: Duffy D L; Macdonald A M; Easton D F; Ponder B A; Martin N G
Is the genetics of moliness simply the genetics of sun exposure? A path analysis of nevus counts and risk factors in British twins.
Cytogenetics and cell genetics 1992;59(2-3):194-6.
1992: Easton D F; Cox G M; Macdonald A M; Ponder B A
The study of nevi in British twins: study design and description of the data set.
Cytogenetics and cell genetics 1992;59(2-3):165-6.
1992: Weiming X; Yu Q; Lizhi L; Ponder M; Wallace M; Gangfeng X; Ponder B
Molecular analysis of neurofibromatosis type 1 mutations.
Human mutation 1992;1(6):474-7.
1991: Easton D F; Cox G M; Macdonald A M; Ponder B A
Genetic susceptibility to naevi--a twin study.
British journal of cancer 1991;64(6):1164-7.
1991: Gardner E; Rydberg B; Karran P; Ponder B A
Localization of the human O6-methylguanine-DNA methyltransferase gene to chromosome 10q24.33-qter.
Genomics 1991;11(2):475-6.
1991: Mulligan L M; Gardner E; Papi L; Ponder B A
A new polymorphism in the ret protooncogene (RET).
Nucleic acids research 1991;19(20):5795.
1991: Xu W; Liu L; Black D M; Ponder B A
A BglII polymorphism in the human NF1 gene.
Nucleic acids research 1991;19(17):4798.
1991: Xu W; Liu L; Ponder M; Ponder B A
A TaqI polymorphism in the human NF1 gene.
Nucleic acids research 1991;19(16):4570.
1991: Xu W; Liu L; Ponder B A
A BamHI polymorphism in the human EVI2A gene (human homolog of the murine gene Evi-2).
Nucleic acids research 1991;19(9):2520.
1991: Mathew C G; Easton D F; Nakamura Y; Ponder B A
Presymptomatic screening for multiple endocrine neoplasia type 2A with linked DNA markers. The MEN 2A International Collaborative Group.
Lancet 1991;337(8732):7-11.
1990: Winton D J; Gooderham N J; Boobis A R; Davies D S; Ponder B A
Mutagenesis of mouse intestine in vivo using the Dlb-1 specific locus test: studies with 1,2-dimethylhydrazine, dimethylnitrosamine, and the dietary mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline.
Cancer research 1990;50(24):7992-6.
1990: Maher E R; Bentley E; Yates J R; Barton D; Jennings A; Fellows I W; Ponder M A; Ponder B A; Benjamin C; Harris R
Mapping of von Hippel-Lindau disease to chromosome 3p confirmed by genetic linkage analysis.
Journal of the neurological sciences 1990;100(1-2):27-30.
1990: Norum R A; Lafreniere R G; O'Neal L W; Nikolai T F; Delaney J P; Sisson J C; Sobol H; Lenoir G M; Ponder B A; Willard H F
Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A.
Genomics 1990;8(2):313-7.
1990: Ponder B A
Inherited predisposition to cancer.
Trends in genetics : TIG 1990;6(7):213-8.
1990: Winton D J; Ponder B A
Stem-cell organization in mouse small intestine.
Proceedings. Biological sciences / The Royal Society 1990;241(1300):13-8.
1990: Telenius H; Mathew C G; Nakamura Y; Easton D F; Clark J; Neumann H P; Ziegler W H; Schinzel A; Ponder B A
Application of linked DNA markers to screening families with multiple endocrine neoplasia type 2A.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1990;16(2):134-40.
1990: Ponder B A
Prospects for genetic diagnosis of inherited predisposition to cancer.
Trends in biotechnology 1990;8(4):98-104.
1990: Jadayel D; Fain P; Upadhyaya M; Ponder M A; Huson S M; Carey J; Fryer A; Mathew C G; Barker D F; Ponder B A
Paternal origin of new mutations in von Recklinghausen neurofibromatosis.
Nature 1990;343(6258):558-9.
1990: Ponder B
Multiple endocrine neoplasia type 2.
BMJ (Clinical research ed.) 1990;300(6723):484-5.
1990: Telenius H; Clark J; Marcus E; Royle N; Jeffreys A J; Ponder B A; Mathew C G
Minisatellite DNA profiles: rapid sample identification in linkage analysis.
Human heredity 1990;40(2):77-80.
1989: Winton D J; Peacock J H; Ponder B A
Effect of gamma radiation at high- and low-dose rate on a novel in vivo mutation assay in mouse intestine.
Mutagenesis 1989;4(5):404-6.
1989: Winton D J; Blount M A; Ponder B A
Polyclonal origin of mouse skin papillomas.
British journal of cancer 1989;60(1):59-63.
1989: Landsvater R M; Mathew C G; Smith B A; Marcus E M; te Meerman G J; Lips C J; Geerdink R A; Nakamura Y; Ponder B A; Buys C H
Development of multiple endocrine neoplasia type 2A does not involve substantial deletions of chromosome 10.
Genomics 1989;4(3):246-50.
1989: Easton D F; Ponder M A; Cummings T; Gagel R F; Hansen H H; Reichlin S; Tashjian A H; Telenius-Berg M; Ponder B A
The clinical and screening age-at-onset distribution for the MEN-2 syndrome.
American journal of human genetics 1989;44(2):208-15.
1989: Telenius-Berg M; Ponder M A; Berg B; Ponder B A; Werner S
Quality of life after bilateral adrenalectomy in MEN 2.
Henry Ford Hospital medical journal 1989;37(3-4):160-3.
1988: Marcus E M; Smith B A; Telenius H; Landsvater R M; Buys C H; Ferrari S; Ponder B A; Mathew C G
BclI RFLP for the human vimentin gene.
Nucleic acids research 1988;16(18):9068.
1988: Winton D J; Blount M A; Ponder B A
A clonal marker induced by mutation in mouse intestinal epithelium.
Nature 1988;333(6172):463-6.
1988: Ponder B A; Finer N; Coffey R; Harmer C L; Maisey M; Ormerod M G; Pembrey M E; Ponder M A; Rosswick P; Shalet S
Family screening in medullary thyroid carcinoma presenting without a family history.
The Quarterly journal of medicine 1988;67(252):299-308.
1988: Chin K S; Mathew C G; Fong S L; Bridges C D; Ponder B A
Styl RFLP recognised by a human IRBP cDNA localised to chromosome 10.
Nucleic acids research 1988;16(4):1645.
1988: Ponder B A; Ponder M A; Coffey R; Pembrey M E; Gagel R F; Telenius-Berg M; Semple P; Easton D F
Risk estimation and screening in families of patients with medullary thyroid carcinoma.
Lancet 1988;1(8582):397-401.
1987: Skolnick M H; Ponder B; Seizinger B
Linkage of NF1 to 12 chromosome 17 markers: a summary of eight concurrent reports.
Genomics 1987;1(4):382-3.
1987: Ponder B A
Familial cancer: opportunities for clinical practice and research.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1987;13(6):463-73.
1987: Mathew C G; Thorpe K; Easton D F; Carter C; Wallis C; Wong Z; Jeffreys A J; Ponder B A
Linkage analysis of British and Indian families with Von Recklinghausen neurofibromatosis.
Journal of medical genetics 1987;24(9):524-6.
1987: Mathew C G; Smith B A; Thorpe K; Wong Z; Royle N J; Jeffreys A J; Ponder B A
Deletion of genes on chromosome 1 in endocrine neoplasia.
Nature 1987;328(6130):524-6.
1987: Schmidt G H; Blount M A; Ponder B A
Immunochemical demonstration of the clonal organization of chimaeric mouse epidermis.
Development (Cambridge, England) 1987;100(3):535-41.
1987: Ponder B A; Jeffreys A J; Hartley N E; Carter C; Easton D F; Telenius H; Telenius-Berg M
Application of minisatellite DNA probes to linkage in MEN-2.
Henry Ford Hospital medical journal 1987;35(2-3):161-3.
1987: Carter C; Easton D F; Mathew C G; Welander G; Telenius H; Telenius-Berg M; Ponder B A
Exclusion of linkage of loci on chromosome 19 with multiple endocrine neoplasia, type 2.
Cytogenetics and cell genetics 1987;45(1):33-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Bruce Ponder

Research Profile (preview)

Disorders

Physiology

Chemicals & Drugs

Genes & Molecular Sequences

Concepts & Ideas

Anatomy

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Bruce Ponder (preview)

All Publications